Chicago-based alternative real estate investor Harrison Street has entered the UK biotech sector with the acquisition of a portfolio of five life sciences and innovation properties across the country for a price of around £250 mln (€300 mln).
Private asset management company Kryalos has completed the acquisition of a light industrial property in Rome, through its Mars fund.
